Evanston

Forging a Path to Racial Justice

Retrieved on: 
Friday, June 19, 2020

This has come to pass against a backdrop of longstanding racial injustice in virtually every aspect of American life.

Key Points: 
  • This has come to pass against a backdrop of longstanding racial injustice in virtually every aspect of American life.
  • It creates the moral imperative to act, and to view all aspects of our personal, social, and institutional lives through the lens of justice.
  • If we do this, we could soon find ourselves in the midst of a mass transition toward racial justice.
  • Let us then join hands with each other in commitment to the path of justice.

Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder

Retrieved on: 
Thursday, June 18, 2020

The completion of enrollment in our Phase 2 exploratory study of PTSD represents an important clinical development milestone for our company, said Norbert Riedel, Ph.D., president and chief executive officer of Aptinyx.

Key Points: 
  • The completion of enrollment in our Phase 2 exploratory study of PTSD represents an important clinical development milestone for our company, said Norbert Riedel, Ph.D., president and chief executive officer of Aptinyx.
  • The Phase 2 study duration is ten to thirteen weeks overall, consisting of a screening period, two treatment periods, and a safety follow-up period.
  • The data from this first-in-patient, exploratory, Phase 2 study are expected to inform future development plans for NYX-783 in PTSD.
  • NYX-783 is a novel, oral NMDA receptor modulator currently in Phase 2 development for the treatment of post-traumatic stress disorder (PTSD).

Aptinyx to Present at Upcoming Virtual Investor Conferences

Retrieved on: 
Tuesday, June 16, 2020

ET and;

Key Points: 
  • ET and;
    SVB Leerink CybeRx Series: 2nd Annual CNS Forum on Wednesday June 24, 2020 at 1:15 p.m.
  • A live webcast of each presentation will be available on the Events and Presentations page in the Investors & Media section of Aptinyxs website at https://ir.aptinyx.com .
  • A replay of the webcast will be archived on Aptinyxs website for 30 days following the event.
  • Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders.

Persecution of Iran’s Baha’is ramped up: threats to “uproot”, prison sentences and psychological pressures

Retrieved on: 
Wednesday, June 10, 2020

In a court hearing held for a group of Bahais in Shiraz, a court official threatened to uproot the Bahais in the city.

Key Points: 
  • In a court hearing held for a group of Bahais in Shiraz, a court official threatened to uproot the Bahais in the city.
  • The court sentenced the Bahais to one to 13 years in prison.
  • The recent pressures come as Irans state-affiliated media have also stepped up the public defamation of the Bahais through an increasingly coordinated spread of disinformation.
  • The Bahais targeted in these incidents, and indeed all Bahais facing discrimination, are innocent and must be free of religious persecution.

Houthis continue to hold pardoned Baha’i prisoners of conscience during pandemic

Retrieved on: 
Wednesday, June 3, 2020

Washington, D.C., June 03, 2020 (GLOBE NEWSWIRE) -- Six Bahai prisoners of conscience remain imprisoned by Yemens Houthi authorities, despite COVID-19 spreading to prisons in Sanaa and warnings from the UN that the virus is multiplying fast in the country.

Key Points: 
  • Washington, D.C., June 03, 2020 (GLOBE NEWSWIRE) -- Six Bahai prisoners of conscience remain imprisoned by Yemens Houthi authorities, despite COVID-19 spreading to prisons in Sanaa and warnings from the UN that the virus is multiplying fast in the country.
  • The BIC reported that two detainees in the Central Prison of Sanaa have been diagnosed with COVID-19, thereby heightening the risk of it spreading widely throughout the prison.
  • The Office of the United Nations High Commissioner for Human Rights has called for prisoners of conscience to be released to protect them from the higher risk of infection in prisons.
  • Moreover, UN human rights experts have called for the immediate and unconditional release of the six Bahai detainees.

Former University of Illinois President Robert Easter Joins The 2Blades Foundation Sustainability Council

Retrieved on: 
Thursday, May 28, 2020

It is a noble calling and I am delighted to have this opportunity to contribute in any way that I can."

Key Points: 
  • It is a noble calling and I am delighted to have this opportunity to contribute in any way that I can."
  • Dr. Easter was appointed president-designate of the University of Illinois in March 2012, and became the university's 19th president in July 2012 until his retirement in 2015.
  • The 2Blades Foundation, based in Evanston, Illinois, and with offices and laboratories in the United Kingdom, is a 501(c)(3) charitable organization.
  • 2Blades establishes and manages development programs addressing significant unsolved crop disease problems in collaboration with leading research institutions around the world in both the public and private sectors.

Baha’is in Iran face accelerated persecution despite public health crisis

Retrieved on: 
Monday, May 18, 2020

Geneva, May 18, 2020 (GLOBE NEWSWIRE) -- While the COVID-19 pandemic continues to hit Iran particularly hard, the Iranian government has further intensified its persecution of its Bahai community.

Key Points: 
  • Geneva, May 18, 2020 (GLOBE NEWSWIRE) -- While the COVID-19 pandemic continues to hit Iran particularly hard, the Iranian government has further intensified its persecution of its Bahai community.
  • The international community has been calling for Iran to release its prisoners of conscience, owing to the high risk of death associated with COVID-19 in prisons.
  • During this global pandemic, when prisons are hotbeds of infection, returning these Bahais to prison is akin to handing down a death sentence.
  • Bahais in Iran have faced systematic persecution since the 1979 Islamic Revolution.

Fidus Investment Corporation Notice of Change to Annual Meeting of Stockholders

Retrieved on: 
Monday, May 18, 2020

EVANSTON, Ill., May 18, 2020 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (Fidus or the Company) announced today a change in location for its Annual Meeting of Stockholders (the Annual Meeting) to be held on Thursday, June 4, 2020 at 9:00 a.m. Central Time.

Key Points: 
  • EVANSTON, Ill., May 18, 2020 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (Fidus or the Company) announced today a change in location for its Annual Meeting of Stockholders (the Annual Meeting) to be held on Thursday, June 4, 2020 at 9:00 a.m. Central Time.
  • Except for the change of location of the Annual Meeting, all other details of the Annual Meeting, including the proposals to be proposed at the meeting, remain unchanged.
  • As described in the proxy materials for the Annual Meeting previously distributed, stockholders are entitled to participate in and vote at the Annual Meeting if they were a stockholder as of the close of business on the record date, March 13, 2020.
  • The Companys board of directors urges all of the Companys stockholders to appoint a proxy to ensure their vote counts at the Annual Meeting.

Aptinyx Reports First Quarter 2020 Financial Results and Highlights

Retrieved on: 
Thursday, May 14, 2020

Following study completion, Aptinyx anticipates reporting data from this study late in 2020.

Key Points: 
  • Following study completion, Aptinyx anticipates reporting data from this study late in 2020.
  • Collaboration Revenue: Revenue was $0.8 million for the first quarter of 2020 compared to $0.9 million for same period in 2019.
  • Net Loss: For the first quarter of 2020, net loss was $14.7 million compared to a net loss of $16.7 million for the first quarter 2019.
  • The Aptinyx management team will host a conference call and webcast today at 5:00 p.m. EDT to review its financial results and highlights for the first quarter of 2020 and subsequent period.

Fidus Investment Corporation Announces First Quarter 2020 Financial Results

Retrieved on: 
Thursday, April 30, 2020

Our total portfolio investments at fair value were approximately 98.3% of the related cost basis as of March 31, 2020.

Key Points: 
  • Our total portfolio investments at fair value were approximately 98.3% of the related cost basis as of March 31, 2020.
  • First quarter 2020 investment activity included the following new portfolio company investments:
    Combined Systems, Inc., a leading designer, manufacturer, and marketer of non-lethal security products for the global defense and law enforcement markets.
  • The final determination of 2020 taxable income, as well as the tax attributes for 2020 dividends, will be made after the close of the 2020 tax year.
  • Management will host a conference call to discuss the operating and financial results at 9:00am ET on Friday, May 1, 2020.